Using a New Shunt for Malignant Ascites
Author Information
Author(s): Tokue Hiroyuki, Takeuchi Yoshito, Arai Yasuaki, Sofue Keitaro, Sakamoto Noriaki, Tsushima Yoshito, Endo Keigo
Primary Institution: Gunma University Hospital, Maebashi, Gunma, Japan; National Cancer Center Hospital, Tokyo, Japan
Hypothesis
To evaluate a new modified peritoneovenous shunt therapy, the externalized peritoneovenous shunt (EPVS) system placement, used to treat patients with malignant ascites.
Conclusion
EPVS placement may be an option for patients with malignant ascites who may not be appropriate for conventional PVS placement.
Supporting Evidence
- EPVS was successfully placed in all patients.
- EPVS provided clinical efficacy in 8 patients (80%).
- The median duration of EPVS placement was 10.4 days.
- In 6 patients (60%), the EPVS was exchanged to conventional PVS sequentially.
Takeaway
Doctors tested a new way to help patients with a lot of fluid in their belly from cancer. It worked for most of the patients.
Methodology
Retrospective review of 10 patients with malignant ascites who underwent EPVS placement.
Limitations
The study was retrospective, had a small number of patients, and a very short follow-up period.
Participant Demographics
3 men and 7 women; mean age 52 years (range 22-69).
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website